ImmUniverse Consortium: Multi-omics integrative approach in personalized medicine for immune-mediated inflammatory diseases

Medicine and Dentistry

• Biological Marker 100%
• Personalized Medicine 100%
• Inflammatory Disorder 100%
• Tamsulosin 100%
• Disease Severity 66%
• Disease Exacerbation 66%
• Atopic Dermatitis 66%
• Diseases 66%
• Combination Therapy 33%
• Medicine 33%
• Clinician 33%
• Organ Systems 33%
• Gut 33%
• Chronic Inflammation 33%
• Quality of Life 33%
• Prematurity 33%
• Rheumatoid Arthritis 33%
• Immune Response 33%
• Ulcerative Colitis 33%
• Treatment Response 33%
• Psoriasis 33%
• Drug Efficacy 33%
• Side Effect 33%
• Inflammatory Bowel Disease 33%
• Comorbidity 33%
• Inflammatory Arthritis 33%
• Immune Dysregulation 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Tamsulosin 100%
• Inflammatory Disease 100%
• Biological Marker 100%
• Disease Severity 66%
• Disease Exacerbation 66%
• Atopic Dermatitis 66%
• Diseases 66%
• Inflammatory Bowel Disease 33%
• Ulcerative Colitis 33%
• Prematurity 33%
• Rheumatoid Arthritis 33%
• Side Effect 33%
• Chronic Inflammation 33%
• Combination Therapy 33%
• Comorbidity 33%
• Psoriasis 33%
• Inflammatory Arthritis 33%
• Immune Dysregulation 33%